Press Releases
April 5, 2018
Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and Tesi
May 9, 2017
BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development
March 7, 2017
Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics
March 2, 2017
Debiopharm Strategic Fund announces FDA clearance of Portfolio Company Immunexpress’ first Test
August 30, 2016
Debiopharm invests double digit millions in the Canadian startup GenePOC, specialized in the development of rapid diagnostic tests
January 13, 2015
Debiopharm Diagnostics leads investment round in GenePOC with Emerillon Capital
September 17, 2014
Debiopharm Diagnostics portfolio company Biocartis ships its first Idylla instrument